Lurbinectedin Superior to Topotecan for Treating SCLC
U.S. Pharmacist » Lung Cancer
by
5d ago
..read more
Visit website
Risk Factors for Lung Cancer in Nonsmokers
U.S. Pharmacist » Lung Cancer
by
5d ago
..read more
Visit website
PD-1 Inhibitors Associated With Greater Pneumonitis Risk
U.S. Pharmacist » Lung Cancer
by
5d ago
..read more
Visit website
Review of Selected NMEs 2023
U.S. Pharmacist » Lung Cancer
by
6M ago
Spotlighting newly approved medications that treat anemia due to chronic kidney disease, breast cancer, leukemia, and lung cancer ..read more
Visit website
A Look at NSCLC and Its Current and Emerging Therapies
U.S. Pharmacist » Lung Cancer
by
10M ago
Oncology pharmacists can identify drug-related problems associated with conventional and emerging NSCLC therapies and educate about side effects, monitoring, and drug interactions ..read more
Visit website
Postmenopausal Hormone Therapy Lowers Risk of Lung Cancer
U.S. Pharmacist » Lung Cancer
by
10M ago
..read more
Visit website
Postmenopausal Hormone Therapy Lowers Risk of Lung Cancer
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Cost Effectiveness of Risk-Based Lung Cancer Screening
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Targeted Therapies Underused in Medicaid Programs
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Impact of NSAIDs on Immunotherapy Efficacy in NSCLC
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website

Follow U.S. Pharmacist » Lung Cancer on FeedSpot

Continue with Google
Continue with Apple
OR